Company’s 36-month beta value is 1.00.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for INGN is 23.43M, and currently, short sellers hold a 3.25% ratio of that floaft. The average trading volume of INGN on January 10, 2025 was 186.12K shares.
INGN) stock’s latest price update
Inogen Inc (NASDAQ: INGN)’s stock price has soared by 3.74 in relation to previous closing price of 9.37. Nevertheless, the company has seen a gain of 6.00% in its stock price over the last five trading days. zacks.com reported 2024-12-31 that INGN announces FDA clearance for the SIMEOX 200 Airway Clearance Device.
INGN’s Market Performance
Inogen Inc (INGN) has experienced a 6.00% rise in stock performance for the past week, with a 2.32% rise in the past month, and a 5.77% rise in the past quarter. The volatility ratio for the week is 4.99%, and the volatility levels for the past 30 days are at 4.60% for INGN. The simple moving average for the past 20 days is 7.62% for INGN’s stock, with a 5.85% simple moving average for the past 200 days.
Analysts’ Opinion of INGN
JP Morgan, on the other hand, stated in their research note that they expect to see INGN reach a price target of $8, previously predicting the price at $15. The rating they have provided for INGN stocks is “Neutral” according to the report published on August 08th, 2023.
INGN Trading at 3.24% from the 50-Day Moving Average
After a stumble in the market that brought INGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -27.08% of loss for the given period.
Volatility was left at 4.60%, however, over the last 30 days, the volatility rate increased by 4.99%, as shares surge +2.21% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.31% upper at present.
During the last 5 trading sessions, INGN rose by +6.00%, which changed the moving average for the period of 200-days by +37.48% in comparison to the 20-day moving average, which settled at $9.03. In addition, Inogen Inc saw 6.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at INGN starting from JASON SOMER, who proposed sale 4,690 shares at the price of $12.03 back on Aug 09 ’24. After this action, JASON SOMER now owns shares of Inogen Inc, valued at $56,423 using the latest closing price.
Somer Jason, the EVP, Gen. Counsel & Secretary of Inogen Inc, sale 10,000 shares at $8.56 during a trade that took place back on May 10 ’24, which means that Somer Jason is holding 4,452 shares at $85,600 based on the most recent closing price.
Stock Fundamentals for INGN
Current profitability levels for the company are sitting at:
- -0.16 for the present operating margin
- 0.45 for the gross margin
The net margin for Inogen Inc stands at -0.16. The total capital return value is set at -0.22. Equity return is now at value -25.33, with -16.21 for asset returns.
Currently, EBITDA for the company is -58.34 million with net debt to EBITDA at 2.07. When we switch over and look at the enterprise to sales, we see a ratio of 0.44. The receivables turnover for the company is 9.68for trailing twelve months and the total asset turnover is 1.08. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.66.
Conclusion
In a nutshell, Inogen Inc (INGN) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
